Edges in Network
| Network | GSE16391_top8000 - GSE16391 - SiGN-BN NNSR |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | ENO2 |
| Upstream (Parents) |
|---|
| (<<) ARHGDIB → ENO2 |
| (<<) SH2D4A → ENO2 |
| (<<) GLS2 → ENO2 |
| (<<) WNT3 → ENO2 |
| (<<) BCL11A → ENO2 |
| (<<) DHRS13 → ENO2 |
| (<<) PGRMC1 → ENO2 |
| Downstream (Children) |
|---|
| ENO2 → SH2D4A (>>) |
| ENO2 → RHOV (>>) |
| ENO2 → CD163L1 (>>) |
| ENO2 → GLS2 (>>) |
| ENO2 → SLPI (>>) |
| ENO2 → WNT3 (>>) |
| ENO2 → PGRMC1 (>>) |
| ENO2 → FADS1 (>>) |
| ENO2 → DOK7 (>>) |
| ENO2 → SC65 (>>) |
